Trial Profile
Bioavailability of Subcutaneously Given Dexmedetomidine in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2020
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Dexmedetomidine (Primary)
- Indications Cancer pain; Pain; Sedation; Subarachnoid haemorrhage
- Focus Pharmacokinetics
- Acronyms ScDex
- 27 May 2020 Data from this trial used to develop semi-mechanistic population models for predicting pharmacokinetic and pharmacodynamic profiles of dexmedetomidine after intravenous and subcutaneous dosing published in the Clinical Pharmacokinetics
- 11 Sep 2017 Status changed from active, no longer recruiting to completed.
- 19 Oct 2016 Planned primary completion date changed from 1 May 2016 to 1 Dec 2016.